1,877
Views
45
CrossRef citations to date
0
Altmetric
Original Article

Influence of phospholipid types and animal models on the accelerated blood clearance phenomenon of PEGylated liposomes upon repeated injection

, , , , , , & show all
Pages 598-607 | Received 13 Dec 2013, Accepted 17 Jan 2014, Published online: 13 Feb 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Marwa Mohamed, Amr S. Abu Lila, Taro Shimizu, Eman Alaaeldin, Amal Hussein, Hatem A. Sarhan, Janos Szebeni & Tatsuhiro Ishida. (2019) PEGylated liposomes: immunological responses. Science and Technology of Advanced Materials 20:1, pages 710-724.
Read now
Yan Fang, Jianxiu Xue, Shan Gao, Anqi Lu, Dongjuan Yang, Hong Jiang, Yang He & Kai Shi. (2017) Cleavable PEGylation: a strategy for overcoming the “PEG dilemma” in efficient drug delivery. Drug Delivery 24:2, pages 22-32.
Read now
Xiao Hu, Feifei Yang, Yonghong Liao, Lin Li & Lan Zhang. (2017) Cholesterol–PEG comodified poly (N-butyl) cyanoacrylate nanoparticles for brain delivery: in vitro and in vivo evaluations. Drug Delivery 24:1, pages 121-132.
Read now

Articles from other publishers (42)

Jiaxuan Xia, Chen Chen, Meichen Dong, Ying Zhu, Anni Wang, Shiyi Li, Ru Zhang, Chunbo Feng, Xinnan Jiang, Xinchun Xu & Jianxin Wang. (2023) Ginsenoside Rg3 endows liposomes with prolonged blood circulation and reduced accelerated blood clearance. Journal of Controlled Release 364, pages 23-36.
Crossref
Sherif A. Gaballa, Taro Shimizu, Hidenori Ando, Haruka Takata, Sherif E. Emam, Eslam Ramadan, Youssef W. Naguib, Fatma M. Mady, Khaled A. Khaled & Tatsuhiro Ishida. (2023) Treatment-induced and Pre-existing Anti-peg Antibodies: Prevalence, Clinical Implications, and Future Perspectives. Journal of Pharmaceutical Sciences.
Crossref
Christopher N. Subasic, Neville J. Butcher, Rodney F. Minchin & Lisa M. Kaminskas. (2023) Dose-Dependent Production of Anti-PEG IgM after Intramuscular PEGylated-Hydrogenated Soy Phosphatidylcholine Liposomes, but Not Lipid Nanoparticle Formulations of DNA, Correlates with the Plasma Clearance of PEGylated Liposomal Doxorubicin in Rats. Molecular Pharmaceutics 20:7, pages 3494-3504.
Crossref
Rumiana Tenchov, Janet M. Sasso & Qiongqiong Angela Zhou. (2023) PEGylated Lipid Nanoparticle Formulations: Immunological Safety and Efficiency Perspective. Bioconjugate Chemistry 34:6, pages 941-960.
Crossref
Melody D. Fulton & Wided Najahi-Missaoui. (2023) Liposomes in Cancer Therapy: How Did We Start and Where Are We Now. International Journal of Molecular Sciences 24:7, pages 6615.
Crossref
Peichun Peng, Zeshan Chen, Miaodong Wang, Bin Wen & Xin Deng. (2023) Polysaccharide‐modified liposomes and their application in cancer research. Chemical Biology & Drug Design 101:4, pages 998-1011.
Crossref
Yao Wang, Ming Jia, Xiu Zheng, Chenglong Wang, Yun Zhou, Hong Pan, Yan Liu, Ji Lu, Zhiqiang Mei & Chunhong Li. (2022) Microvesicle-camouflaged biomimetic nanoparticles encapsulating a metal-organic framework for targeted rheumatoid arthritis therapy. Journal of Nanobiotechnology 20:1.
Crossref
Mária Klacsová, Adriána Čelková, Alexander Búcsi, Juan Carlos Martínez & Daniela Uhríková. (2022) Interaction of GC376, a SARS-COV-2 MPRO inhibitor, with model lipid membranes. Colloids and Surfaces B: Biointerfaces 220, pages 112918.
Crossref
B. Oktay, G.Ö. Eroğlu, S. Demir, S.E. Kuruca & N.K. Apohan. (2022) Poly(lactic acid) nanofibers containing phosphorylcholine grafts for transdermal drug delivery systems. Materials Today Sustainability 18, pages 100132.
Crossref
Ahmed M. Abu-Dief, Mosa Alsehli & Aziz Awaad. (2022) A higher dose of PEGylated gold nanoparticles reduces the accelerated blood clearance phenomenon effect and induces spleen B lymphocytes in albino mice. Histochemistry and Cell Biology 157:6, pages 641-656.
Crossref
Soohyung Park, Yeol Kyo Choi, Seonghoon Kim, Jumin Lee & Wonpil Im. (2021) CHARMM-GUI Membrane Builder for Lipid Nanoparticles with Ionizable Cationic Lipids and PEGylated Lipids. Journal of Chemical Information and Modeling 61:10, pages 5192-5202.
Crossref
Nicola Micale, Maria Sofia Molonia, Andrea Citarella, Francesco Cimino, Antonina Saija, Mariateresa Cristani & Antonio Speciale. (2021) Natural Product-Based Hybrids as Potential Candidates for the Treatment of Cancer: Focus on Curcumin and Resveratrol. Molecules 26:15, pages 4665.
Crossref
Liwang Shi, Jinqiu Zhang, Man Zhao, Shukun Tang, Xu Cheng, Wenyuan Zhang, Wenhua Li, Xiaoying Liu, Haisheng Peng & Qun Wang. (2021) Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery. Nanoscale 13:24, pages 10748-10764.
Crossref
Ruyi Wang, Zhongtao Zhang, Bowen Liu, Jingwei Xue, Fulei Liu, Tongzhong Tang, Wenyuan Liu, Feng Feng & Wei Qu. (2021) Strategies for the design of nanoparticles: starting with long-circulating nanoparticles, from lab to clinic. Biomaterials Science 9:10, pages 3621-3637.
Crossref
Mehak Rastogi, Ranendra Narayan Saha, Amit Alexander, Gautam Singhvi, Anu Puri & Sunil Kumar Dubey. (2021) Role of stealth lipids in nanomedicine-based drug carriers. Chemistry and Physics of Lipids 235, pages 105036.
Crossref
Federico Mazur & Rona Chandrawati. (2021) Membrane Fusion Models for Bioapplications. ChemNanoMat 7:3, pages 223-237.
Crossref
Phillip W. Askenase. (2021) Ancient Evolutionary Origin and Properties of Universally Produced Natural Exosomes Contribute to Their Therapeutic Superiority Compared to Artificial Nanoparticles. International Journal of Molecular Sciences 22:3, pages 1429.
Crossref
Catia T. Perciani, Lewis Y. Liu, Lawrence Wood & Sonya A. MacParland. (2020) Enhancing Immunity with Nanomedicine: Employing Nanoparticles to Harness the Immune System. ACS Nano 15:1, pages 7-20.
Crossref
Saeed A. AlQahtani, Gamaleldin I. Harisa, Abdullah H. Alomrani, Fars K. Alanazi & Mohamed M. Badran. (2021) Improved pharmacokinetic and biodistribution of 5-fluorouracil loaded biomimetic nanoerythrocytes decorated nanocarriers for liver cancer treatment. Colloids and Surfaces B: Biointerfaces 197, pages 111380.
Crossref
Masahiro Tokuno, Kazuaki Taguchi, Keishi Yamasaki & Masaki Otagiri. (2020) Hepatic Cytochrome P450 Profiles in Hemorrhagic Shock Model Rats After Transfusion With Stored Red Blood Cells. Journal of Pharmaceutical Sciences 109:11, pages 3490-3495.
Crossref
Leitgeb Maja, Knez Željko & Primožič Mateja. (2020) Sustainable technologies for liposome preparation. The Journal of Supercritical Fluids 165, pages 104984.
Crossref
Nicola d'Avanzo, Christian Celia, Antonella Barone, Maria Carafa, Luisa Di Marzio, Hélder A. Santos & Massimo Fresta. (2020) Immunogenicity of Polyethylene Glycol Based Nanomedicines: Mechanisms, Clinical Implications and Systematic Approach. Advanced Therapeutics 3:3.
Crossref
Collin T. Inglut, Aaron J. Sorrin, Thilinie Kuruppu, Shruti Vig, Julia Cicalo, Haroon Ahmad & Huang-Chiao Huang. (2020) Immunological and Toxicological Considerations for the Design of Liposomes. Nanomaterials 10:2, pages 190.
Crossref
Gergely Tibor Kozma, Taro Shimizu, Tatsuhiro Ishida & Janos Szebeni. (2020) Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals. Advanced Drug Delivery Reviews 154-155, pages 163-175.
Crossref
Fengling Wang, Huihui Wang, Yifan Wu, Lei Wang, Ling Zhang, Xi Ye, Daiyin Peng & Weidong Chen. (2019) Activation of Pregnane X Receptor–Cytochrome P450s Axis: A Possible Reason for the Enhanced Accelerated Blood Clearance Phenomenon of PEGylated Liposomes In Vivo. Drug Metabolism and Disposition 47:8, pages 785-793.
Crossref
Wooseung Lee & Hyung-Jun Im. (2019) Theranostics Based on Liposome: Looking Back and Forward. Nuclear Medicine and Molecular Imaging 53:4, pages 242-246.
Crossref
Yaelle Bavli, Ilan Winkler, Bing Mae Chen, Steve Roffler, Rivka Cohen, Janos Szebeni & Yechezkel Barenholz. (2019) Doxebo (doxorubicin-free Doxil-like liposomes) is safe to use as a pre-treatment to prevent infusion reactions to PEGylated nanodrugs. Journal of Controlled Release 306, pages 138-148.
Crossref
Fahimeh Zahednezhad, Maryam Saadat, Hadi Valizadeh, Parvin Zakeri-Milani & Behzad Baradaran. (2019) Liposome and immune system interplay: Challenges and potentials. Journal of Controlled Release 305, pages 194-209.
Crossref
Fengling Wang, Yifan Wu, Jiwen Zhang, Huihui Wang, Xiaoting Xie, Xi Ye, Daiyin Peng & Weidong Chen. (2019) Induction of Cytochrome P450 Involved in the Accelerated Blood Clearance Phenomenon Induced by PEGylated Liposomes In Vivo. Drug Metabolism and Disposition 47:4, pages 364-376.
Crossref
Fengling Wang, Xi Ye, Yifan Wu, Huihui Wang, Chengming Sheng, Daiyin Peng & Weidong Chen. (2019) Time Interval of Two Injections and First-Dose Dependent of Accelerated Blood Clearance Phenomenon Induced by PEGylated Liposomal Gambogenic Acid: The Contribution of PEG-Specific IgM. Journal of Pharmaceutical Sciences 108:1, pages 641-651.
Crossref
Keegan Curry & Jill Steinbach-Rankins. (2018) A comparison of emulsion-based and electrosprayed particle architectures to sustain the release of small hydrophilic agents. A comparison of emulsion-based and electrosprayed particle architectures to sustain the release of small hydrophilic agents.
Yang Liu, Bin Xie, Lin Li, Xinyu Zhang, Yu Zhang, Haibing He, Tian Yin, Xing Tang, Cuifang Cai & Jingxin Gou. (2018) PEGylated lipid microspheres loaded with cabazitaxel for intravenous administration: stability, bioavailability, antitumor efficacy, and toxicity. Drug Delivery and Translational Research 8:5, pages 1365-1379.
Crossref
Samantha M. Fix, A. Gloria Nyankima, Morgan D. McSweeney, James K. Tsuruta, Samuel K. Lai & Paul A. Dayton. (2018) Accelerated Clearance of Ultrasound Contrast Agents Containing Polyethylene Glycol is Associated with the Generation of Anti-Polyethylene Glycol Antibodies. Ultrasound in Medicine & Biology 44:6, pages 1266-1280.
Crossref
Hidenori Ando, Amr S. Abu Lila, Munehira Kawanishi, Taro Shimizu, Keiichiro Okuhira, Yu Ishima & Tatsuhiro Ishida. (2018) Reactivity of IgM antibodies elicited by PEGylated liposomes or PEGylated lipoplexes against auto and foreign antigens. Journal of Controlled Release 270, pages 114-119.
Crossref
Juhi Samal, Secil Demir & Abhay Pandit. 2018. Drug Delivery Nanosystems for Biomedical Applications. Drug Delivery Nanosystems for Biomedical Applications 91 151 .
Amr S. Abu Lila, Taro Shimizu & Tatsuhiro Ishida. 2018. Engineering of Biomaterials for Drug Delivery Systems. Engineering of Biomaterials for Drug Delivery Systems 51 68 .
Calvin Cheung & Wafa T. Al-Jamal. 2018. Nanooncology. Nanooncology 51 87 .
Yuqing Su, Wenya Tang, Yanzhi Song, Chunling Wang, Qingjing Tian, Xuling Wang, Jingjing Quan, Buoqun Li, Shaoning Wang & Yihui Deng. (2017) Mixed PEGylated surfactant modifying system decrease the accelerated blood clearance phenomenon of nanoemulsions in rats. Asian Journal of Pharmaceutical Sciences 12:1, pages 28-36.
Crossref
Quan Zhang, Caifeng Deng, Yao Fu, Xun Sun, Tao Gong & Zhirong Zhang. (2016) Repeated Administration of Hyaluronic Acid Coated Liposomes with Improved Pharmacokinetics and Reduced Immune Response. Molecular Pharmaceutics 13:6, pages 1800-1808.
Crossref
Jung Soo Suk, Qingguo Xu, Namho Kim, Justin Hanes & Laura M. Ensign. (2016) PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Advanced Drug Delivery Reviews 99, pages 28-51.
Crossref
Mai Hashimoto, Kazuaki Taguchi, Shigeru Ogaki, Hiroshi Watanabe, Manabu Kinoshita, Kahoko Nishikawa, Shinji Takeoka, Yasuo Ikeda, Makoto Handa, Masaki Otagiri & Toru Maruyama. (2015) Pharmacokinetic Properties of Single and Repeated Injection of Liposomal Platelet Substitute in a Rat Model of Red Blood Cell Transfusion-Induced Dilutional Thrombocytopenia. Journal of Pharmaceutical Sciences 104:11, pages 3968-3976.
Crossref
Qi Yang & Samuel K. Lai. (2015) Anti-PEG immunity: emergence, characteristics, and unaddressed questions. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 7:5, pages 655-677.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.